GPR56/ADGRG1 is associated with response to antidepressant treatment

Archive ouverte

Belzeaux, Raoul | Gorgievski, Victor | Fiori, Laura, M | Lopez, Juan Pablo | Grenier, Julien | Lin, Rixing | Nagy, Corina | Ibrahim, El Chérif | Gascon, Eduardo | Courtet, Philippe | Richard-Devantoy, Stéphane | Berlim, Marcelo | Chachamovich, Eduardo | Théroux, Jean-François | Dumas, Sylvie | Giros, Bruno | Rotzinger, Susan | Soares, Claudio, N | Foster, Jane, A | Mechawar, Naguib | Tall, Gregory, G | Tzavara, Eleni, T | Kennedy, Sidney, H | Turecki, Gustavo

Edité par CCSD ; Nature Publishing Group -

International audience. It remains unclear why many patients with depression do not respond to antidepressant treatment. In three cohorts of individuals with depression and treated with serotonin-norepinephrine reuptake inhibitor (N = 424) we show that responders, but not non-responders, display an increase of GPR56 mRNA in the blood. In a small group of subjects we also show that GPR56 is downregulated in the PFC of individuals with depression that died by suicide. In mice, we show that chronic stress-induced Gpr56 downregulation in the blood and prefrontal cortex (PFC), which is accompanied by depression-like behavior, and can be reversed by antidepressant treatment. Gpr56 knockdown in mouse PFC is associated with depressive-like behaviors, executive dysfunction and poor response to antidepressant treatment. GPR56 peptide agonists have antidepressant-like effects and upregulated AKT/ GSK3/EIF4 pathways. Our findings uncover a potential role of GPR56 in antidepressant response.

Suggestions

Du même auteur

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants

Archive ouverte | Lin, Rixing | CCSD

International audience. Pharmacotherapies for the treatment of major depressive disorder were serendipitously discovered almost seven decades ago. From this discovery, scientists pinpointed the monoaminergic system ...

Antidepressive effects of targeting ELK-1 signal transduction

Archive ouverte | Apazoglou, Kallia | CCSD

International audience. Depression, a devastating psychiatric disorder, is a leading cause of disability worldwide. Current antidepressants address specific symptoms of the disease, but there is vast room for improv...

miR-323a regulates ERBB4 and is involved in depression.

Archive ouverte | Fiori, Laura, M | CCSD

International audience. Major depressive disorder (MDD) is a complex and debilitating illness whose etiology remains unclear. Small RNA molecules, such as micro RNAs (miRNAs) have been implicated in MDD, where they ...

Chargement des enrichissements...